Botox maker Allergan, in deal talks with Pfizer, said revenue in its latest quarter nearly doubled as demand for the company’s branded pharmaceuticals and medical-aesthetics products soared.
from WSJ.com: US Business http://ift.tt/1XPpQ6S
via IFTTT
No comments:
Post a Comment